Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative lidocaine for recovery after radical gastrectomy in gastric cancer
ChiCTR2000028934Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in gastric cancer (GC) (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Quality of Recovery-40 score. Started Dec 2019; status: recruiting.
02
Drugs
lidocaine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2000028934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028934.